newsfilter
← Latest News
GlobeNewswire·

Telesis Bio to Present at Antibody Engineering and Therapeutics, Europe 2023

SAN DIEGO, June 06, 2023 (GLOBE NEWSWIRE) -- Telesis Bio Inc. (NASDAQ:TBIO), a leader in automated multi-omic and synthetic biology solutions, today announced they will be showcasing their automated workflow solutions